UKAD 2015 BWLA vs Andrew Riddiford

Facts
The British Weight Lifting Association (BWLA) alleged Andrew Riddiford, the athlete, for a violation of the Anti-Doping rules. On March 8, 2015, UKAD collected an in-competition sample from the Athlete. Analysis of the sample showed the presence of a metabolite of stanozolol and clenbuterol. Stanozolol and clenbuterol are prohibited substances according the World Anti-Doping Agency (WADA) 2015 prohibited list. They are regarden as non-specified substances.

History
The athlete admitted the charge and waved his right for a B sample analysis.

Decision
- The period of ineligibility is four years.
- The period of ineligibility is deemed to have commenced from March 8, 2015, and will end at midnight on March 7, 2019.

Original document

Parameters

Legal Source
National Decisions
Date
26 May 2015
Original Source
Irish Sports Council (ISC)
Country
Ireland
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
British Weight Lifting Association (BWLA)
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S1. Anabolic Agents
Substances
Clenbuterol
Stanozolol
Document type
Pdf file
Date generated
19 June 2015
Date of last modification
13 July 2015
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin